Yale/NIDA Neuroproteomics Center Project Investigators

Name	Department	Institution	Website	Project Title
James Bibb	Psychiatry	University of Alabama at Birmingham	James A. Bibb, Ph.D.	Ventral Striatal Addiction, Inflammation, and Metabolic Syndrome Signaling
Thomas Biederer	Neurology	Yale University	Thomas Biederer, Ph.D.	Identification and Analysis of Synapse-Organizing Complexes in Addiction-Relevant Brain Regions
Sreeganga Chandra	Neurology	Yale University	Sreeganga Chandra, Ph.D.	Neuronal Substrates Required for Synapse Maintenance
Christopher Cowan	Neuroscience, Psychiatry	Medical University of South Carolina	Christopher Cowan, Ph.D.	Analysis of ROS-Sensitive HDAC5 PTMs and Identification of HDAC5 Repressor Complexes in Rats Self-Administering Cocaine or Heroin
Pietro De Camilli	Cell Biology	Yale University	Pietro De Camilli, M.D.	Membrane Traffic and Lipid Dynamics in Neuronal Function
Lakshmi Devi	Pharmacology & Systems Therapeutics	Icahn School of Medicine at Mount Sinai	Lakshmi Devi, Ph.D.	Identification of Novel Modulators of Opioid Receptor Signaling During Drug Addiction
John Elsworth	Psychiatry	Yale University	John Elsworth, Ph.D.	Age-dependent Protection and Vulnerability to Drugs of Abuse in Nonhuman Primates
Christie Fowler	Neurobiology and Behavior	University of California, Irvine	Christie Fowler, Ph.D .	Proteomic Analysis of the Impact of Nicotine and THC on Extracellular Vesicle Signaling
William N. Green	Neurobiology	University of Chicago	William N. Green, Ph.D.	Proteomic Assays of Nicotine-induced Golgi Fragments and Changes in Glycosylation
Stephanie Groman	Neuroscience, Medical Discovery Team on Addiction	U. Minnesota	Stephanie Groman, Ph.D .	Protein Mechanisms of Drug Use Susceptibility
Yasmin Hurd	Pharmacological Sciences, Neuroscience, Psychiatry	Icahn School of Medicine at Mount Sinai	Yasmin Hurd, PH.D.	Proteomic Analysis of Neural Epigenetic Mechanisms and Immune System Underlying Long-Lasting Effects of Developmental Cannabis Exposure
Leonard K. Kaczmarek	Pharmacology, Cellular and Molecular Physiology	Yale University	Leonard K. Kaczmarek, Ph.D.	Modulation of Potassium Channels by Protein Phosphorylation and Interacting Auxiliary Proteins
Paul J. Kenny	Pharmacology, and Systems Therapeutics	Icahn School of Medicine at Mount Sinai	Paul J. Kenny, Ph.D.	Mechanisms by Which Tcf7l2 Controls Addiction-relevant Gene Expression in the Habenula
Drew Kiraly	Psychiatry, Neuroscience	Icahn School of Medicine at Mount Sinai	Drew Kiraly, M.D.; Ph.D.	Neuroimmune and Microbiome Effects on Limbic Reward Structures in Models of Substance Use Disorders
Michael R. Koelle	Molecular Biophysics & Biochemistry	Yale University	Michael R. Koelle, Ph.D.	Proteomic Analysis of Complexes formed by the Neural G Protein Gαo
Ryan Logan	Pharmacology & Experimental Therapeutics	Boston University	Ryan Logan, Ph.D.	The Impact of Morphine on the Diurnal Variation of Protein Expression in the Dorsal Striatum
Ken Mackie	Psychological and Brain Sciences	Indiana University	Ken Mackie, M.D.	Effects of Phytocannabinoids on the Developing Cerebellum
S tephen J. Moss	Department of Neuroscience	Tufts University	Stephen J. Moss	Analyzing the Effects of Benzodiazepines on the Structure and Phosphorylation of Type A γ-Aminobutyric Acid Receptors
Angus Nairn	Psychiatry	Yale University	Angus Nairn, Ph.D.	Regulation of Synaptic Structure and Function by Drugs of Abuse
Eric Nestler	Chair, Neuroscience	Icahn School of Medicine at Mount Sinai	Eric Nestler, Ph.D., M.D.	Proteomic Profiling of Drug-induced Alterations to the Brain Reward System Underlying Addiction
Marina Picciotto	Psychiatry, Pharmacology, Neurobiology	Yale University	Marina Picciotto, Ph.D.	Proteomics of Altered Signaling in Nicotine Addiction
Paul Slesinger	Neuroscience	Icahn School of Medicine at Mount Sinai	Paul Slesinger, Ph.D.	Characterization of Changes in the GIRK Channel Proteome with Psychostimulants
Stephen Strittmatter	Neurobiology, Neurology	Yale University	Stephen Strittmatter, M.D., Ph.D.	Proteomic Basis for Chronic Anatomical Plasticity of Synapses
Jane Taylor	Psychiatry	Yale University	Jane Taylor, Ph.D.	Proteomic Analysis of Cellular Alterations Associated with Drug-Induced Impairments in Decision-Making, Mnemonic Processes and Relapse Behaviors
Susumu Tomita	Cellular and Molecular Physiology	Yale University	Susumu Tomita, Ph.D.	Identification of Altered Phosphorylation Signaling in Neurotransmission
Mary Torregrossa	Psychiatry	University of Pittsburgh	Mary Torregrossa, Ph.D.	Identifying Changes in Protein Signaling that Regulate Substance Use Vulnerability, Craving, and Relapse.